uric acid and avapro

uric acid has been researched along with avapro in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's4 (23.53)29.6817
2010's8 (47.06)24.3611
2020's3 (17.65)2.80

Authors

AuthorsStudies
Brunner, HR; Burnier, M; Nussberger, J; Pechère-Bertschi, A; Waeber, B1
Guthrie, R; Kassler-Taub, K; Kochar, M; Reeves, RA; Triscari, J1
Brunner, HR; Burnier, M; Chiolero, A; Fallab-Stubi, CL; Gerster, JC; Maillard, M; Würzner, G1
Christides, D; Elisaf, M; Liberopoulos, E1
Chen, G; Dang, A; Liu, G; Song, W; Wang, B; Zhang, Y1
Chen, GL; Dang, AM; Liu, GZ; Zhang, YH1
Anzai, N; Ichida, K; Jutabha, P; Nakamura, M; Sakurai, H; Sato, H1
Bakker, SJ; Berl, T; Cooper, ME; de Zeeuw, D; Lambers Heerspink, HJ; Laverman, GD; Smink, PA1
de Zeeuw, D; Lambers Heerspink, HJ; Parving, HH; Rossing, P; Schievink, B1
Fukuda, H; Ishibashi, K; Ishimitsu, T; Nagao, M; Nukui, K; Sato, F; Uchida, M1
Chida, R; Hisauchi, I; Hori, Y; Inoue, T; Kikuchi, M; Komatsu, T; Nakahara, S; Sakai, Y; Taguchi, I; Toyoda, S1
Adachi, S; Fujisawa, K; Inoue, T; Kusumoto, T; Miura, S; Motozato, K; Saku, K; Shiga, Y1
Anzai, N; Hamada, T; Hirota, Y; Hisatome, I; Ikeda, N; Kato, M; Kuwabara, M; Maharani, N; Mishima, M; Miyazaki, S; Mizuta, E; Ninomiya, H; Notsu, T; Ogino, K; Onohara, T; Otani, N; Sugihara, S; Yoshida, A1
Okamura, K; Okuda, T; Shirai, K; Totake, N; Urata, H1
Kim, H; Kim, HS; Kim, JH; Lee, SH1
Hasebe, N; Koyama, S; Maruyama, J; Morimoto, H; Nakagawa, N; Nakamura, Y; Ogawa, Y; Ohta, T; Saijo, Y; Sato, N; Takeuchi, T; Uekita, K1
Huang, QF; Li, Y; Wang, JG; Zhang, D1

Trials

9 trial(s) available for uric acid and avapro

ArticleYear
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
    American journal of hypertension, 1999, Volume: 12, Issue:8 Pt 1

    Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diuretics; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Potassium; Sample Size; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Tetrazoles; Uric Acid

1999
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Journal of hypertension, 2001, Volume: 19, Issue:10

    Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Chronic Disease; Cross-Over Studies; Double-Blind Method; Gout; Humans; Hypertension; Irbesartan; Losartan; Male; Middle Aged; Prospective Studies; Tetrazoles; Uric Acid

2001
Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population.
    Journal of human hypertension, 2006, Volume: 20, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Asian People; Biphenyl Compounds; Blood Pressure; China; Double-Blind Method; Female; Humans; Hypertension; Hyperuricemia; Incidence; Irbesartan; Losartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Uric Acid

2006
[The effects of angiotensin II receptor blockers in hypertensive patients complicating hyperuricaemia].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:10

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Losartan; Male; Middle Aged; Tetrazoles; Uric Acid

2006
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials.
    Journal of hypertension, 2012, Volume: 30, Issue:5

    Topics: Adult; Aged; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular System; Data Interpretation, Statistical; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Middle Aged; Placebos; Proportional Hazards Models; Risk; Risk Factors; Tetrazoles; Treatment Outcome; Uric Acid

2012
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers.
    British journal of clinical pharmacology, 2015, Volume: 80, Issue:4

    Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Female; Hemoglobins; Humans; Individuality; Irbesartan; Kidney; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Potassium; Prospective Studies; Risk Factors; Tetrazoles; Uric Acid

2015
Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:11

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Biphenyl Compounds; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Oxidative Stress; Tetrazoles; Uric Acid

2015
Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2016, Volume: 38, Issue:1

    Topics: Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Triglycerides; Uric Acid; Valsartan

2016
Assessment of suitable antihypertensive therapies: Combination with high-dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI-AI study).
    Journal of clinical hypertension (Greenwich, Conn.), 2020, Volume: 22, Issue:9

    Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Artificial Intelligence; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Irbesartan; Prospective Studies; Tetrazoles; Treatment Outcome; Uric Acid

2020

Other Studies

8 other study(ies) available for uric acid and avapro

ArticleYear
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 26, Issue:1

    Topics: Adult; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Humans; Imidazoles; Irbesartan; Kidney; Kidney Tubules; Losartan; Natriuresis; Potassium; Renin-Angiotensin System; Sodium; Sodium, Dietary; Tetrazoles; Uric Acid; Vasomotor System; Water

1995
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
    Journal of hypertension, 2002, Volume: 20, Issue:2

    Topics: Antihypertensive Agents; Biphenyl Compounds; Gout; Humans; Hypertension; Irbesartan; Losartan; Tetrazoles; Uric Acid

2002
Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters.
    Journal of pharmacological sciences, 2010, Volume: 114, Issue:1

    Topics: Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Irbesartan; Kidney; Organic Anion Transporters; Organic Cation Transport Proteins; Tetrazoles; Uric Acid; Xenopus

2010
The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:7

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Product Surveillance, Postmarketing; Proteinuria; Surveys and Questionnaires; Tetrazoles; Treatment Outcome; Uric Acid

2015
Effects of Uric Acid on the NO Production of HUVECs and its Restoration by Urate Lowering Agents.
    Drug research, 2016, Volume: 66, Issue:5

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzbromarone; Biphenyl Compounds; Cells, Cultured; Glucose Transport Proteins, Facilitative; Human Umbilical Vein Endothelial Cells; Humans; Irbesartan; Losartan; Monocarboxylic Acid Transporters; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Tetrazoles; Uric Acid; Uricosuric Agents

2016
Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:2

    Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Irbesartan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Uric Acid

2018
Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6

    Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Female; Humans; Hyperuricemia; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Retrospective Studies; Tetrazoles; Time Factors; Uric Acid

2020
Incident hyperuricemia in relation to antihypertensive therapy with the irbesartan/hydrochlorothiazide combination.
    Blood pressure monitoring, 2021, Dec-01, Volume: 26, Issue:6

    Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Hyperuricemia; Irbesartan; Tetrazoles; Uric Acid

2021